Skip to main content
  • Mini Review
  • Published:

Role of inflammasomes and their regulators in prostate cancer initiation, progression and metastasis

Abstract

Prostate cancer is one of the main cancers that affect men, especially older men. Though there has been considerable progress in understanding the progression of prostate cancer, the drivers of its development need to be studied more comprehensively. The emergence of resistant forms has also increased the clinical challenges involved in the treatment of prostate cancer. Recent evidence has suggested that inflammation might play an important role at various stages of cancer development. This review focuses on inflammasome research that is relevant to prostate cancer and indicates future avenues of study into its effective prevention and treatment through inflammasome regulation. With regard to prostate cancer, such research is still in its early stages. Further study is certainly necessary to gain a broader understanding of prostate cancer development and to create successful therapy solutions.

Abbreviations

AIM2:

absent in melanoma 2

ASC:

apoptosis-associated specklike protein containing caspase recruitment domain

IFN:

interferon

IFI16:

interferon gamma-inducible protein-16

IL:

interleukin

IL-1R1:

interleukin-1 receptor 1

MyD88:

myeloid differentiation factor 88

NF-κB:

nuclear factor of kappa light polypeptide gene enhancer in B-cells

NLR:

NOD-like leucine-rich repeat-containing receptor

NOD:

nucleotide oligomerization domain

PIA:

proliferative inflammatory atrophy

PPR:

pathogen-associated pattern recognition receptor

PSA:

prostate-specific antigen

SNP:

single nucleotide polymorphisms

References

  1. Siegel, R., DeSantis, C., Virgo, K., Stein, K., Mariotto, A., Smith, T., Cooper, D., Gansler, T., Lerro, C., Fedewa, S., Lin, C., Leach, C., Cannady, R.S., Cho, H., Scoppa, S., Hachey, M., Kirch, R., Jemal, A. and Ward, E. Cancer treatment and survivorship statistics, 2012. CA. Cancer J. Clin. 62 (2012) 220–241.

    Article  PubMed  Google Scholar 

  2. Tewari, A.K. and George, D.J. Novel chemotherapies in development for management of castration-resistant prostate cancer. Curr. Opin. Urol. (2013). DOI: 10.1097/MOU.0b013e32835f7da2.

    Google Scholar 

  3. De Marzo, A.M., Platz, E.A., Sutcliffe, S., Xu, J., Gronberg, H., Drake, C.G., Nakai, Y., Isaacs, W.B. and Nelson, W.G. Inflammation in prostate carcinogenesis. Nat. Rev. Cancer 7 (2007) 256–269.

    Article  PubMed  Google Scholar 

  4. Haverkamp, J., Charbonneau, B. and Ratliff, T.L. Prostate inflammation and its potential impact on prostate cancer: a current review. J. Cell Biochem. 103 (2008) 1344–1353.

    Article  CAS  PubMed  Google Scholar 

  5. Kazma, R., Mefford, J.A., Cheng, I., Plummer, S.J., Levin, A.M., Rybicki, B.A., Casey, G. and Witte, J.S. Association of the innate immunity and inflammation pathway with advanced prostate cancer risk. PLoS One 7 (2012) e51680.

    Article  CAS  PubMed  Google Scholar 

  6. Kwon, E.M., Salinas, C.A., Kolb, S., Fu, R., Feng, Z., Stanford, J.L. and Ostrander, E.A. Genetic polymorphisms in inflammation pathway genes and prostate cancer risk. Cancer Epidemiol. Biomarkers Prev. 20 (2011) 923–933.

    Article  CAS  PubMed  Google Scholar 

  7. Sfanos, K.S. and De Marzo, A.M. Prostate cancer and inflammation: the evidence. Histopathology 60 (2012) 199–215.

    Article  PubMed  Google Scholar 

  8. Stock, D., Groome, P.A. and Siemens, D.R. Inflammation and prostate cancer: a future target for prevention and therapy? Urol. Clin. North Am. 35 (2008) 117–130, vii.

    Article  PubMed  Google Scholar 

  9. MacLennan, G.T., Eisenberg, R., Fleshman, R.L., Taylor, J.M., Fu, P., Resnick, M.I. and Gupta, S. The influence of chronic inflammation in prostatic carcinogenesis: a 5-year followup study. J. Urol. 176 (2006) 1012–1016.

    Article  PubMed  Google Scholar 

  10. Billis, A., Freitas, L.L., Magna, L.A. and Ferreira, U. Inflammatory atrophy on prostate needle biopsies: is there topographic relationship to cancer? Int. Braz. J. Urol. 33 (2007) 355–360; discussion 361–353.

    Article  PubMed  Google Scholar 

  11. Billis, A. and Magna, L.A. Inflammatory atrophy of the prostate. Prevalence and significance. Arch. Pathol. Lab. Med. 127 (2003) 840–844.

    PubMed  Google Scholar 

  12. Montironi, R., Vela Navarrete, R., Lopez-Beltran, A., Mazzucchelli, R., Mikuz, G. and Bono, A.V. Histopathology reporting of prostate needle biopsies. 2005 update. Virchows Arch. 449 (2006) 1–13.

    Article  PubMed  Google Scholar 

  13. Billis, A. Re: Inflammatory atrophy on prostate needle biopsies: is there topographic relationship to cancer? Int. Braz. J. Urol. 33 (2007) 566–568.

    Article  PubMed  Google Scholar 

  14. Schroder, K. and Tschopp, J. The inflammasomes. Cell 140 (2010) 821–832.

    Article  CAS  PubMed  Google Scholar 

  15. Zitvogel, L., Kepp, O., Galluzzi, L. and Kroemer, G. Inflammasomes in carcinogenesis and anticancer immune responses. Nat. Immunol. 13 (2012) 343–351.

    Article  CAS  PubMed  Google Scholar 

  16. Dunn, J.H., Ellis, L.Z. and Fujita, M. Inflammasomes as molecular mediators of inflammation and cancer: potential role in melanoma. Cancer Lett. 314 (2012) 24–33.

    Article  CAS  PubMed  Google Scholar 

  17. Guo, Y. and Kyprianou, N. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis. Cancer Res. 59 (1999) 1366–1371.

    CAS  PubMed  Google Scholar 

  18. Winter, R.N., Kramer, A., Borkowski, A. and Kyprianou, N. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res. 61 (2001) 1227–1232.

    CAS  PubMed  Google Scholar 

  19. Bruckheimer, E.M. and Kyprianou, N. Bcl-2 antagonizes the combined apoptotic effect of transforming growth factor-beta and dihydrotestosterone in prostate cancer cells. Prostate 53 (2002) 133–142.

    Article  CAS  PubMed  Google Scholar 

  20. Sasaki, Y., Ahmed, H., Takeuchi, T., Moriyama, N. and Kawabe, K. Immunohistochemical study of Fas, Fas ligand and interleukin-1 beta converting enzyme expression in human prostatic cancer. Br. J. Urol. 81 (1998) 852–855.

    Article  CAS  PubMed  Google Scholar 

  21. Nikitina, E.Y., Desai, S.A., Zhao, X., Song, W., Luo, A.Z., Gangula, R.D., Slawin, K.M. and Spencer, D.M. Versatile prostate cancer treatment with inducible caspase and interleukin-12. Cancer Res. 65 (2005) 4309–4319.

    Article  CAS  PubMed  Google Scholar 

  22. Winter, R.N., Rhee, J.G. and Kyprianou, N. Caspase-1 enhances the apoptotic response of prostate cancer cells to ionizing radiation. Anticancer Res. 24 (2004) 1377–1386.

    CAS  PubMed  Google Scholar 

  23. Hasegawa, M., Kawase, K., Inohara, N., Imamura, R., Yeh, W.C., Kinoshita, T. and Suda, T. Mechanism of ASC-mediated apoptosis: biddependent apoptosis in type II cells. Oncogene 26 (2007) 1748–1756.

    Article  CAS  PubMed  Google Scholar 

  24. Collard, R.L., Harya, N.S., Monzon, F.A., Maier, C.E. and O’Keefe, D.S. Methylation of the ASC gene promoter is associated with aggressive prostate cancer. Prostate 66 (2006) 687–695.

    Article  CAS  PubMed  Google Scholar 

  25. Das, P.M., Ramachandran, K., Vanwert, J., Ferdinand, L., Gopisetty, G., Reis, I.M. and Singal, R. Methylation mediated silencing of TMS1/ASC gene in prostate cancer. Mol. Cancer 5 (2006) 28.

    Article  PubMed  Google Scholar 

  26. Gurjar, M.V., DeLeon, J., Sharma, R.V. and Bhalla, R.C. Mechanism of inhibition of matrix metalloproteinase-9 induction by NO in vascular smooth muscle cells. J. Appl. Physiol. 91 (2001) 1380–1386.

    CAS  PubMed  Google Scholar 

  27. Petrella, B.L., Armstrong, D.A. and Vincenti, M.P. Interleukin-1 beta and transforming growth factor-beta 3 cooperate to activate matrix metalloproteinase expression and invasiveness in A549 lung adenocarcinoma cells. Cancer Lett. 325 (2012) 220–226.

    Article  CAS  PubMed  Google Scholar 

  28. Nakao, S., Kuwano, T., Tsutsumi-Miyahara, C., Ueda, S., Kimura, Y.N., Hamano, S., Sonoda, K.H., Saijo, Y., Nukiwa, T., Strieter, R.M., Ishibashi, T., Kuwano, M. and Ono, M. Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. J. Clin. Invest. 115 (2005) 2979–2991.

    Article  CAS  PubMed  Google Scholar 

  29. Tsuzaki, M., Guyton, G., Garrett, W., Archambault, J.M., Herzog, W., Almekinders, L., Bynum, D., Yang, X. and Banes, A.J. IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J. Orthop. Res. 21 (2003) 256–264.

    Article  CAS  PubMed  Google Scholar 

  30. Maggio, M., Basaria, S., Ceda, G.P., Ble, A., Ling, S.M., Bandinelli, S., Valenti, G. and Ferrucci, L. The relationship between testosterone and molecular markers of inflammation in older men. J. Endocrinol. Invest. 28 (2005) 116–119.

    CAS  PubMed  Google Scholar 

  31. Saylor, P.J., Kozak, K.R., Smith, M.R., Ancukiewicz, M.A., Efstathiou, J.A., Zietman, A.L., Jain, R.K. and Duda, D.G. Changes in biomarkers of inflammation and angiogenesis during androgen deprivation therapy for prostate cancer. Oncologist 17 (2012) 212–219.

    Article  CAS  PubMed  Google Scholar 

  32. Vykhovanets, E.V., Shukla, S., MacLennan, G.T., Vykhovanets, O.V., Bodner, D.R. and Gupta, S. Il-1 beta-induced post-transition effect of NFkappaB provides time-dependent wave of signals for initial phase of intrapostatic inflammation. Prostate 69 (2009) 633–643.

    Article  CAS  PubMed  Google Scholar 

  33. Klein, R.D., Borchers, A.H., Sundareshan, P., Bougelet, C., Berkman, M.R., Nagle, R.B. and Bowden, G.T. Interleukin-1beta secreted from monocytic cells induces the expression of matrilysin in the prostatic cell line LNCaP. J. Biol. Chem. 272 (1997) 14188–14192.

    Article  CAS  PubMed  Google Scholar 

  34. Lebel-Binay, S., Thiounn, N., De Pinieux, G., Vieillefond, A., Debre, B., Bonnefoy, J.Y. and Fridman, W.H., Pages, F. IL-18 is produced by prostate cancer cells and secreted in response to interferons. Int. J. Cancer 106 (2003) 827–835.

    Article  CAS  PubMed  Google Scholar 

  35. Veeranki, S., Duan, X., Panchanathan, R., Liu, H. and Choubey, D. IFI16 protein mediates the anti-inflammatory actions of the type-I interferons through suppression of activation of caspase-1 by inflammasomes. PLoS One 6 (2011) e27040.

    Article  CAS  PubMed  Google Scholar 

  36. Fujita, K., Ewing, C.M., Isaacs, W.B. and Pavlovich, C.P. Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status. Int. J. Cancer 129 (2011) 424–432.

    Article  CAS  PubMed  Google Scholar 

  37. Veeranki, S. and Choubey, D. Interferon-inducible p200-family protein IFI16, an innate immune sensor for cytosolic and nuclear double-stranded DNA: regulation of subcellular localization. Mol. Immunol. 49 (2012) 567–571.

    Article  CAS  PubMed  Google Scholar 

  38. Xin, H., Curry, J., Johnstone, R.W., Nickoloff, B.J. and Choubey, D. Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence. Oncogene 22 (2003) 4831–4840.

    Article  CAS  PubMed  Google Scholar 

  39. Cahu, J., Bustany, S. and Sola, B. Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells. Cell Death Dis. 3 (2012) e446.

    Article  CAS  PubMed  Google Scholar 

  40. Choubey, D. DNA-responsive inflammasomes and their regulators in autoimmunity. Clin. Immunol. 142 (2012) 223–231.

    Article  CAS  PubMed  Google Scholar 

  41. Lamkanfi, M. and Dixit, V.M. Inflammasomes and their roles in health and disease. Annu. Rev. Cell Dev. Biol. 28 (2012) 137–161.

    Article  CAS  PubMed  Google Scholar 

  42. Olsson, J., Drott, J.B., Laurantzon, L., Laurantzon, O., Bergh, A. and Elgh, F. Chronic prostatic infection and inflammation by Propionibacterium acnes in a rat prostate infection model. PLoS One 7 (2012) e51434.

    Article  CAS  PubMed  Google Scholar 

  43. Shinohara, D.B., Vaghasia, A.M., Yu, S.H., Mak, T.N., Bruggemann, H., Nelson, W.G., De Marzo, A.M., Yegnasubramanian, S. and Sfanos, K.S. A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes. Prostate (2013) doi: 10.1002/pros.22648.

    Google Scholar 

  44. Sahdo, B., Sarndahl, E., Elgh, F. and Soderquist, B. Propionibacterium acnes activates caspase-1 in human neutrophils. APMIS (2012) doi: 10.1111/apm.12035.

    Google Scholar 

  45. Nakahira, K., Haspel, J.A., Rathinam, V.A., Lee, S.J., Dolinay, T., Lam, H.C., Englert, J.A., Rabinovitch, M., Cernadas, M., Kim, H.P., Fitzgerald, K.A., Ryter, S.W. and Choi, A.M. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12 (2011) 222–230.

    Article  CAS  PubMed  Google Scholar 

  46. Harris, J., Hartman, M., Roche, C., Zeng, S.G., O’Shea, A., Sharp, F.A., Lambe, E.M., Creagh, E.M., Golenbock, D.T., Tschopp, J., Kornfeld, H., Fitzgerald, K.A. and Lavelle, E.C. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J. Biol. Chem. 286 (2011) 9587–9597.

    Article  CAS  PubMed  Google Scholar 

  47. Menu, P., Mayor, A., Zhou, R., Tardivel, A., Ichijo, H., Mori, K. and Tschopp, J. ER stress activates the NLRP3 inflammasome via an UPRindependent pathway. Cell Death Dis. 3 (2012) e261.

    Article  CAS  PubMed  Google Scholar 

  48. Duncan, J.A., Gao, X., Huang, M.T., O’Connor, B.P., Thomas, C.E., Willingham, S.B., Bergstralh, D.T., Jarvis, G.A., Sparling, P.F. and Ting, J.P. Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. J. Immunol. 182 (2009) 6460–6469.

    Article  CAS  PubMed  Google Scholar 

  49. Abdul-Sater, A.A., Said-Sadier, N., Padilla, E.V. and Ojcius, D.M. Chlamydial infection of monocytes stimulates IL-1beta secretion through activation of the NLRP3 inflammasome. Microbes Infect. 12 (2010) 652–661.

    Article  CAS  PubMed  Google Scholar 

  50. Babolin, C., Amedei, A., Ozolins, D., Zilevica, A., D’Elios, M.M. and de Bernard, M. TpF1 from Treponema pallidum activates inflammasome and promotes the development of regulatory T cells. J. Immunol. 187 (2011) 1377–1384.

    Article  CAS  PubMed  Google Scholar 

  51. Johnson, K.E., Chikoti, L. and Chandran, B. HSV-1 infection induces activation and subsequent inhibition of the IFI16 and NLRP3 inflammasomes. J. Virol. (2013) doi: 10.1128/JVI.00082-13.

    Google Scholar 

  52. Rathinam, V.A., Jiang, Z., Waggoner, S.N., Sharma, S., Cole, L.E., Waggoner, L., Vanaja, S.K., Monks, B.G., Ganesan, S., Latz, E., Hornung, V., Vogel, S.N., Szomolanyi-Tsuda, E. and Fitzgerald, K.A. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 11 (2010) 395–402.

    Article  CAS  PubMed  Google Scholar 

  53. Persson, B.E. and Ronquist, G. Evidence for a mechanistic association between nonbacterial prostatitis and levels of urate and creatinine in expressed prostatic secretion. J. Urol. 155 (1996) 958–960.

    Article  CAS  PubMed  Google Scholar 

  54. Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. and Tschopp, J. Goutassociated uric acid crystals activate the NALP3 inflammasome. Nature 440 (2006) 237–241.

    Article  CAS  PubMed  Google Scholar 

  55. Couillin, I., Vasseur, V., Charron, S., Gasse, P., Tavernier, M., Guillet, J., Lagente, V., Fick, L., Jacobs, M., Coelho, F.R., Moser, R. and Ryffel, B. IL-1R1/MyD88 signaling is critical for elastase-induced lung inflammation and emphysema. J. Immunol. 183 (2009) 8195–8202.

    Article  CAS  PubMed  Google Scholar 

  56. Cohen, T.S. and Prince, A.S. Activation of inflammasome signaling mediates pathology of acute P. aeruginosa pneumonia. J. Clin. Invest. (2013) doi: 10.1172/JCI66142.

    Google Scholar 

  57. Hrbacek, J., Urban, M., Hamsikova, E., Tachezy, R. and Heracek, J. Thirty years of research on infection and prostate cancer: No conclusive evidence for a link. A systematic review. Urol. Oncol. (2012) doi:10.1016/j.urolonc.2012.01.013.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sudhakar Veeranki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Veeranki, S. Role of inflammasomes and their regulators in prostate cancer initiation, progression and metastasis. Cell Mol Biol Lett 18, 355–367 (2013). https://doi.org/10.2478/s11658-013-0095-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11658-013-0095-y

Key words